Entering its third year, the seminar series “The ABC of Viral Hepatitis – From Translational Research to Clinical Practice” has established itself as a key platform for dialogue between basic science and clinical application. Designed to foster interdisciplinary exchange, the series continues to explore how innovative research can be effectively translated into improved care for patients with viral hepatitis.

Each session offers insights into the translational process—from groundbreaking discoveries in immunology and virology to clinical trial data, therapeutic strategies, and real-world experiences. The series not only promotes knowledge sharing but also aims to strengthen long-term collaboration between researchers and clinicians, driving innovation and enhancing patient outcomes.

We are pleased to announce the following speakers:

🔜 Upcoming Sessions – Fall/Winter 2025/2026

27 October 2025, 5 p.m. CET:  Sabela Lens García, M.D., Ph.D. Viral Hepatitis Group, Liver Unit, Hospital Clínic Barcelona, University of Barcelona, FCRB-IDIBAPS, Barcelona / Spain: “Understanding Hepatitis B/Delta: ongoing efforts” Click here for online participation

8 December 2025, 5 p.m. CET:  Prof. Eui-Cheol Shin, M.D., Ph.D. KAIST (Korea Advanced Institute of Science and Technology), Daejeon / Korea: “Cytokine-induced bystander CD8+ T cell activation and its regulation in viral hepatitis” Click here for online participation

26 January 2026, 5 p.m. CET:  Prof. Dr. Maike Hofmann, University of Freiburg, Translational Experimental Immunology, Freiburg / Germany: “T cell exhaustion and beyond: lessons from chronic viral hepatitis” Click here for online participation

Details on upcoming talks will be continuously updated on this homepage.